The INBRIJA Resource Center offers tools and resources to help you. Use these as often as you like. The more you know about OFF periods and your medication, the more your doctor can help you manage your OFF periods.
Treats OFF periods in adults taking carbidopa/levodopa (CD/LD). INBRIJA doesn’t replace CD/LD.
Don’t use if you have taken a nonselective monoamine oxidase inhibitor (eg, phenelzine, tranylcypromine) within the last 2 weeks.
INBRIJA is a prescription medicine used when needed for OFF episodes in adults with Parkinson’s treated with regular carbidopa/levodopa medicine. INBRIJA does not replace regular carbidopa/levodopa medicine.
Do not use INBRIJA if you take or have taken a nonselective monoamine oxidase inhibitor such as phenelzine or tranylcypromine within the last 2 weeks.
Before using INBRIJA, tell your healthcare provider about your medical conditions, including:
Tell your healthcare provider if you take:
Do not drive, operate machinery, or do other activities until you know how INBRIJA affects you. Sleepiness and falling asleep suddenly can happen as late as a year after treatment is started.
Tell your healthcare provider if you experience the following side effects:
The most common side effects of INBRIJA are cough, upper respiratory tract infection, nausea, and change in the color of saliva or spit.
Do not orally inhale more than 1 dose (2 capsules) for any OFF period. Do not take more than 5 doses (10 capsules) in a day.
Please see the Patient Information Leaflet.
You are about to leave Inbrija.com
Please Note: By clicking on this link, you are about to leave Inbrija.com, a website owned and operated by Acorda Therapeutics, Inc.
Acorda Therapeutics, Inc., provides these links as a service to its website visitors and users; however, it does not endorse or take any responsibility for the information presented on any websites but its own.
You are sharing
:The information you provide will be used by Acorda Therapeutics, Inc. in accordance with our Privacy Policy and by parties acting on Acorda's behalf to send them information on INBRIJA. View our Privacy Policy.
When should I use INBRIJA? (Video 1 of 3)
What if I don't hear or feel the whirl when I am using the inhaler? (Video 2 of 3)
What can I do to help with cough when using INBRIJA? (Video 3 of 3)
COVID-19 Update:
Many people are being asked to stay home to slow the spread of COVID-19. INBRIJA® (levodopa inhalation powder) continues to be delivered directly to patients' residences, so you can still receive your medication even if you are homebound for a prolonged period of time.
Prescription Support Services is fully functional and remains available to help you with access, reimbursement, and assistance for INBRIJA. At any time, if you have questions, please contact Prescription Support Services at 1‑888‑887‑3447. Prescription Support Services specialists are available to assist you Monday through Friday from 8 AM to 8 PM eastern time. Also, please visit us online at INBRIJA.com/prescription‑support‑services.
If you have questions or concerns about your treatment plan, please consult your doctor.
If you have questions or concerns related to INBRIJA, please feel free to reach out to us at 1‑800‑367‑5109 or acordamc@eversana.com.
03/20 INB8805
By clicking “GET STARTED” below, you acknowledge and agree that: You are leaving Inbrija.com and going to a third‑party website operated by UpScript, LLC (“UpScript”). Acorda Therapeutics, Inc. is not affiliated with UpScript or any physician on the UpScript website, although it has paid a fee to UpScript to enable this telemedicine service for patients. Physicians are engaged and paid solely by UpScript, and Acorda Therapeutics, Inc. does not in any way, control, influence, endorse, or recommend the qualifications of any physician associated with the UpScript website or the quality of medical care any of those physicians can provide. It is wholly and solely your responsibility to assess the qualifications of a potential physician. Acorda Therapeutics, Inc. makes no guarantees that using the UpScript website will result in your desired outcome. The physician has no obligation to prescribe INBRIJA® (levodopa inhalation powder) and may instead prescribe another medication or no medication. Acorda Therapeutics, Inc. recommends that you discuss the benefits and risks of all potential treatments with the physician. ACORDA THERAPEUTICS, INC. DISCLAIMS ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE PHYSICIAN AND ALL OTHER INFORMATION CONTAINED ON THE UPSCRIPT WEBSITE.
In addition, by clicking “GET STARTED,” you represent that you have commercial prescription drug insurance or no prescription drug insurance and that you are not enrolled in Medicare, Medicaid, or any other state or federal health care program. The UpScript website is available only for patients with commercial insurance or no insurance. If you receive insurance through any government health care program, you may not use this site.
By clicking “GET STARTED” below, you acknowledge and agree that: You are leaving INBRIJA.com and going to a third‑party website operated by UpScript, LLC (“UpScript”). Acorda Therapeutics, Inc. is not affiliated with UpScript or any physician on the UpScript website, although it has paid a fee to UpScript to enable this telemedicine service for patients...